BioHealthonomics Inc.   Report issue

For profit Phase 2
Founded: Santa Monica CA United States (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2015
NCT02021474
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

histamine (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Migraine Disorders (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2